Orexo
Orexo AB, a leading pharmaceutical company headquartered in Sweden, focuses on developing innovative treatments for addiction and pain management. Founded in 1995, Orexo has established a strong presence in Europe and North America, with a commitment to addressing unmet medical needs through advanced drug delivery technologies. The company’s core products, including Zubsolv, a sublingual film for opioid dependence, exemplify its unique approach to patient care. Orexo's dedication to research and development has positioned it as a key player in the pharmaceutical industry, with notable achievements in improving treatment outcomes for patients struggling with addiction. With a robust pipeline and a focus on sustainable growth, Orexo continues to make significant strides in enhancing the quality of life for individuals facing complex health challenges.
DitchCarbon Score
How does Orexo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orexo's score of 39 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Orexo's reported carbon emissions
In 2023, Orexo, headquartered in Sweden (SE), reported total carbon emissions of approximately 1,660,000 kg CO2e. This figure includes 273,000 kg CO2e from Scope 1 emissions, which primarily arise from direct operations, and 73,000 kg CO2e from Scope 2 emissions, associated with purchased electricity. The majority of their emissions, about 1,314,000 kg CO2e, fall under Scope 3, which encompasses indirect emissions from the value chain, including capital goods and business travel. Comparatively, in 2022, Orexo's total emissions were about 1,845,000 kg CO2e, indicating a reduction of approximately 185,000 kg CO2e year-on-year. This reduction reflects the company's ongoing commitment to improving its environmental impact, although specific reduction targets or initiatives have not been disclosed. Orexo's emissions data highlights the importance of addressing both direct and indirect emissions as part of their climate strategy. The company continues to engage in sustainability practices, although further details on specific climate pledges or science-based targets remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 284,000 | 000,000 |
| Scope 2 | 73,000 | 00,000 |
| Scope 3 | 1,488,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orexo is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
